CAP NHAT SIEU AN BINH LUONG MO TRONG GAN PGSTS NGUYEN PHUIC BAO QUAN HG SU Toh que LN THs NIaQ i NTO)mi THEO NATONA CONGRESO VETAMESE SOCIETY OFULTHASOUNDW MEDIC Oddi Tp ul gy 0-09 thing 3 hm 00 Hue ly, arch BH, aah IJTÈI 1 lắm đập hệt VẻthUtryi cla bn Gan hol tứ ).lắn tt tá: Kj that chan dodn iện ta va han ch tỉa dt thuét nay 3 Hib duo ou sb val, nguyen jac kj thud su dm dnh ong mé tong gant mdi 4am dug Ung dung am sng ca cd kj tuat iu Am din ong nổ tong gan he Nm 0á Hội N: 1, TONG QUAN VE GAN THOAI HOA MO) 2 CAC KY THUAT CHAN DOAN GAN THOAI HOA MO HIEN HANH 3 CAC KY THUAT SIEU AM BINH LUONG GAN THOAI HOA MC 4, XACBINH GAN THOAI HOAMO'CO NGUY CO'CA& O VAITRO CUASIEAUM DAN HOI MO GAN, 9 KET LUAN 1101 THEU TONG QUAN VE GAN NHEM MG -Tirdu, ct NAFLD & NASH: of thài hanché tong thy anh LS 1023, AASLD -EASL:- ALEH - Thuật nữ nồi + Bentlygan do thod od me (SLD-Steatotic Liver Disease), bao tim hét cd ol ng mh hn há: tha +Be gan do hol hod mn quan dn RL chuyén hod (MASLD: Metabolc dysfunction-assocated steatoic vedisease J + Ben gan do hol hod mn quan dn RL chuyén hod cst dung regu nhung chua dat nguéng ola ALD (ém gan do tod fod md (MASH-\Vetabolc dysfunction associated nepali etal Amulsocety Deh consensus statement on nw ty er sease nomenclature Hepatology 2023 1101 THEU TONG QUAN VE GAN NHE MMO -J\\lậ lí gan thui há nổ 81) latinh ultC1 trang hin dién cdc git mo tong to gan coc quan sétbéngphuong tin toh anh hog ‘Nas otf: cb ng hg md foe, ot domi a (B25 igh OR HC» on on (OR afdgae lệnh Niên lúc tha [dn nu nt 0 OR ~ MASLD-Bénh \ gat do thodi hod md lién 2p gu 78 mal, ngAcO887R8 mol OR quan dn RL chun od duo x ki gan ‘ype 2b OR ane ype? ables thoibod ng tic ot tong ye [op108e 5 tn y OR apc 1 nguy oo tm mach v ko of ng hn rng no khac (ALD, Met ALD) ‘oyperdtugnVvealenent HALD € 140 glweekim & 210 glveekin), (Panett Ipan () Pa ces h Onn 0 gt) an6 d gl)rOR tg vt ansand Manof NaobogeFaty Liv Dea Pacie Guida FrthoArmca «Dies Help 2018 (GIOITHEU — TONG QUAVE NGAN NHIEM MO May E, Rill et al nulisocity Delhi consensus aterent on nity vet eae nomenclature, Hepatology 2023 ‘GIO THEY TONG QUANVE GAN NHEM WO) Shoat Lr isase (yt os flay magi bo 2228) 1) E Rielle lA slot Delhi consensus tern on ne ÏM hi deae nomena epg203 1.61T0H1EU DICTHE HOC MASLD -Thinh hn cla MASLO trong dns Wile East 31.79%, South America =30.45%h;Afica *13.48%, - Thinh hanh ola MASH trong MASLD : + 20-25% MASLD 9 MASH + 10% MASH > xo hod gan [XG va inh hath| HOC lécac nq.nhan chinh dt vong & bétnathola MASLD - Q/MY, MASLO ng nn ti 3 ola HCC {"|:ZobaiM Younoestal The Epideof mNonilbolilSeotohgpuyts, CLINICAL LIVER DISEASE, VOL II, NO4, APRIL 2018 ) Youn Zea, Glob epidermilogy of nonalcoholic at vet dkat-Meta-antic assessment of revaene, incidence, ues, HEPATOLOGY 2016(6473-4(") Sayin Metal Eider ofonal fat Lie divas and nonaeosabholi inthe Unite ts andthe the worl, Clin Liver Dis 2016;20(2)208-214 16101 THEY GIAIPHAU BENH CUAMASLO - (Dan Bénh hoe ca mang li nghign cu MASH de sua héthdng thang dim d& hn dodn va lvongoé MASLO, he thdng thang idm gdm 14 dd idm mo hoc +4 Gc dé vénhém m6 (03), +: idm v vim tutu) (0-2) +3 dc idm v8 cng tb tb gan (0-2) +4 dc idm v8 xo hod gan (0-3), 1 DE, eal, Design and validatioonf iological sori sem fr nonalcoholic fat et kak, HEPATOLOGY 200, Mu: SINHLY BENH CUAMAS&LHDAU QUA - Tutbn MAS> LThOsvt ola nqubiko | >| BH big MASLO kum - Ngnhén chet thing tung6 bn MASLO = dob im mach,bi gan én quan dn xo gan kh ua - Trsudt bn MASLO tn én dn MASH cao hon sua bn cha bi MASH - QM, MASLO ng ti 3 cla HCC [4 - {34 HOC due tim hay ténnénganchua L "9% obitML Yousa The Epidemiof oNolnaolcgobyoi Steatohepaits, CLINLIIVERCDIASELASE, VOL 1, NO4, L208 ohana Beta, Charatan of hepato crcinoma (CC) in wonacobol fat ler dese (NAFLpaDti) jl chs Hepat ht 20161068289